Skip to contentD
Decoy Therapeutics Inc.
D
DCOYDecoy Therapeutics Inc. Q1 2019 · 10-Q
Revenue$655.64K$655.64K+267.1% vs Q1 2018 Net Income-$1.52M-$1.52MN/M vs Q1 2018 EPS Diluted-$0.64-$0.64N/M vs Q1 2018 Operating Income-$1,532,784N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR
Margins · derivedOperating margin-233.8%+4404.3 pt vs Q1 2018
Net margin-232.2%−18.5 pt vs Q1 2018
ended Mar 31, 2019 · filed May 1, 2019 · 31 d after period end